Moleculin Biotech, Inc. Reports Financial Results for the Third Quarter Ended September 30, 2018
HOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical […]
TG Therapeutics Announces Phase I Study of Novel BTK inhibitor, TG-1701, in Patients with Relapsed or Refractory B-cell Malignancies is Open for Enrollment
First dose cohort fully enrolled First patient enrolled with relapsed/refractory Mantle Cell Lymphoma achieved Partial Response (PR) to lowest dose […]
Eyenovia Announces FDA Acceptance of MicroStat IND Application for Mydriasis
Company on track to initiate Phase III trials in late November NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) — Eyenovia, […]
Cardtronics and Convenience Store Owner Parkland Fuel Partner to Expand ATM Access
280 additional ATM locations to display the TD brand TORONTO, Nov. 13, 2018 (GLOBE NEWSWIRE) — Parkland Fuel Corporation (“Parkland”), […]
TSX News -
ProMIS Neurosciences Announces Third Quarter 2018 Results
TORONTO and CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company […]
Fireweed Drills 7.99% Zinc, 13.26% Lead and 166 g/t Silver over 12.41 m at Tom West
VANCOUVER, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) — FIREWEED ZINC LTD. (“Fireweed” or the “Company”) (TSXV: FWZ) is pleased […]
Tetra Bio-Pharma Promotes Steeve Néron to Senior Vice President, Marketing & Medical Affairs
Tetra Clarifies Estimated Fair Market Value of North Bud Farms Shares ORLEANS, Ontario, Nov. 13, 2018 (GLOBE NEWSWIRE) — Tetra […]
Kwanika Copper Corporation Drills 500 Metres of 0.66% Cu, 0.80g/t Au (2.19 g/t Au Eq) Including 113 Metres of 1.31% Cu, 1.31 g/t Au (4.09 g/t Au Eq) from near surface at Kwanika
VANCOUVER, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) — Serengeti Resources Inc. (SIR: TSX-V) (“Serengeti” or “the Company”) is pleased […]
Magic Delivers Record-Breaking Revenues of $72 Million for the Third Quarter of 2018 with 10% Year over Year Growth
Operating income increased 9% year over year to $7.7 million; Non-GAAP operating income increased 10% to a record-breaking $10.0 million; EPS increased […]
Aptinyx Reports Third Quarter 2018 Financial Results and Business Highlights
Completed enrollment in Phase 2 study of NYX-2925, top-line data anticipated in the first half of 1Q 2019 Reported demonstration […]
